ARGX.BR - argenx SE
NEXT EARNINGS:
Feb 26, 2026
(in 2 days)
EPS Est: $4.56
|
Rev Est: $1.1B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
43.89B
Volume:
46,710
Avg Volume:
78,894
52 Week Range:
456.6-810
Sector:
Healthcare
Industry:
Biotechnology
Beta:
-0.17
Last Dividend:
$N/A
Exchange:
BRU
Country:
NL
Employees:
1,599
IPO Date:
2014-07-10
EPS (TTM):
13.92
P/E Ratio:
50.36
Revenue (TTM):
2.17B
Total Assets:
5.99B
Total Debt:
37.70M
Cash & Equiv:
1.45B
Rev Growth (5Y):
94.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-0.3%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-07-31 | $3.46 | $-0.91 | +480.2% | $948.0M | $916.2M | +3.5% |
| 2025-05-07 | $2.58 | $2.36 | +9.3% | $1.3B | $767.5M | +69.8% |
| 2024-10-31 | $1.39 | $0.01 | +17275.0% | $842.0M | $613.7M | +37.2% |
| 2024-05-09 | $-1.04 | $-0.80 | -30.0% | $686.3M | $377.4M | +81.9% |
| 2023-10-31 | $-1.25 | $-1.43 | +12.6% | $468.2M | $325.6M | +43.8% |
| 2023-05-04 | $-0.52 | $-2.57 | +79.8% | $302.9M | $171.3M | +76.8% |
| 2022-10-27 | $-4.26 | $-3.64 | -17.0% | $111.4M | — | — |
| 2022-05-05 | $-4.36 | $-5.91 | +26.2% | $26.0M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.17B | 1.23B | 410.75M | 497.28M | 41.24M | 78.46M | 24.57M | 43.69M | 15.47M | 7.49M | 4.57M | 3.70M |
| Net Income | 804.13M | (295.05M) | (709.59M) | (408.26M) | (608.46M) | (181.21M) | (76.23M) | (33.68M) | (22.48M) | (16.74M) | (12.54M) | (8.47M) |
| EPS | 13.92 | -5.16 | -13.05 | -7.74 | -13.40 | -4.69 | -2.12 | -1.37 | -1.19 | -1.06 | -0.80 | -0.54 |
| Total Assets | 5.99B | 4.54B | 3.13B | 2.85B | 2.28B | 1.61B | 661.70M | 444.98M | 111.24M | 50.25M | 71.15M | 34.54M |
| Total Debt | 37.70M | 20.00M | 12.43M | 11.46M | 9.66M | 7.32M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 1.45B | 2.05B | 800.74M | 1.33B | 1.22B | 372.16M | 321.48M | 228.98M | 94.54M | 38.83M | 39.13M | 31.37M |
| Operating Cash Flow | (82.75M) | (420.33M) | (862.81M) | (606.81M) | (398.46M) | 151.63M | (61.59M) | (43.84M) | 11.15M | (15.19M) | (6.37M) | (9.12M) |
| Free Cash Flow | (84.55M) | (464.14M) | (966.63M) | (728.25M) | (403.60M) | 104.89M | (62.37M) | (44.27M) | 10.24M | (15.50M) | (6.59M) | (9.21M) |
| FCF per Share | -1.30 | -8.12 | -17.78 | -13.81 | -8.89 | 2.72 | -1.73 | -1.80 | 0.54 | -0.99 | -0.42 | -0.59 |
| Book Value | 5.50B | 4.10B | 2.81B | 2.53B | 1.67B | 1.18B | 615.87M | 413.81M | 66.65M | 40.76M | 60.90M | 29.97M |
| Cash & ST Investments | 3.38B | 3.18B | 2.19B | 2.34B | 2.00B | 1.50B | 645.81M | 431.62M | 101.73M | 46.28M | 68.06M | 32.06M |
| ROC Equity | 0.15 | -0.07 | -0.25 | -0.16 | -0.36 | -0.15 | -0.12 | -0.08 | -0.34 | -0.41 | -0.21 | -0.28 |